RANCHO CORDOVA, Calif.,
Oct. 24, 2019 /PRNewswire/ -- Cesca
Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated
cell processing and autologous cell therapies for regenerative
medicine, today announced Chris Xu,
Ph.D., Chairman and Chief Executive Officer, will present a company
overview at the Dawson James Securities 5th Annual Small
Cap Growth Conference at the Wyndham Grand Hotel in Jupiter, Florida on Tuesday October 29, at 12:45 pm ET.
Management will also be available for one-on-one meetings with
qualified investors. Interested parties can register and
request meetings through the Dawson James conference portal or
contact Rx Communications to schedule a meeting.
A live webcast of the presentation will be available on
Cesca Therapeutics' website
at http://investors.cescatherapeutics.com/events-and-presentations/events.
An archived replay will be available for a period of 90 days after
the conference.
About Cesca Therapeutics Inc.
Cesca
Therapeutics develops, commercializes and markets a range of
automated technologies for CAR-T and other cell-based therapies.
Its device division, ThermoGenesis develops, commercializes and
markets a full suite of solutions for automated clinical
biobanking, point-of-care applications, and automation for
immuno-oncology. The Company has developed a semi- automated,
functionally closed CAR-TXpress™ platform to streamline the
manufacturing process for the emerging CAR-T immunotherapy market.
For more information about Cesca and ThermoGenesis,
please visit: www.cescatherapeutics.com.
Company Contact:
Wendy
Samford
916-858-5191
ir@thermogenesis.com
Investor Contact:
Paula Schwartz, Rx
Communications
917-322-2216
pschwartz@rxir.com
View original
content:http://www.prnewswire.com/news-releases/cesca-therapeutics-to-present-at-the-dawson-james-securities-5th-annual-small-cap-growth-conference-300943746.html
SOURCE Cesca Therapeutics Inc.